$IMXI

IMXI (IMXI) CFO logs routine tax-withholding stock dispositions on Form 4

International Money Express, Inc. (IMXI) CFO Andras Quinn reported two routine tax-related share dispositions on Form 4. These transactions involved the withholding of 1,138 and 948 shares of common stock at $15.78 per share to cover tax obligations related to the vesting of restricted stock units. Quinn still holds over 170,000 direct shares after these non-discretionary events.

Original reporting
Published Mar 3, 2026, 10:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 3, 2026, 11:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$IMXI
Neutral
high confidence
Mentioned
$IMXI
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$IMXINeutralLow
01

Why it matters

These transactions are common and do not indicate strategic changes or insider confidence shifts.

02

Market read

The news is company-specific and pertains to routine insider tax-related transactions, with minimal impact on stock performance.

03

What to watch

Insider transactions are routine and do not necessarily predict future stock performance; broader market conditions should be considered.

Timing: short-term

Background

The CFO reported two routine stock dispositions to cover tax obligations related to vested restricted stock units.

Company-level read

Ticker impact

$IMXINeutralHigh confidence
Context

The news pertains directly to IMXI's insider activity, indicating routine tax-related stock dispositions by the CFO.

Expected impact

Minimal to no impact on stock price; likely to remain within current trading range.

Evidence & confidence

Routine tax-related transactions are common and do not typically signal strategic changes or insider sentiment shifts.

Market effects

Limited; no sector-wide implications from routine insider transactions.

None; specific to company insider activity.

Negligible; company-specific event.

Counterpoint

Some traders might interpret insider dispositions as a sign of potential upcoming liquidity needs or strategic shifts, but evidence here suggests routine activity.

Key entities

  • International Money Express, Inc.

    A provider of money transfer services.

  • Andras Quinn

    CFO of IMXI, reported routine stock dispositions.

Related articles

$WUMedAI 8/10

Western Union Company and International Money Express, Inc. Receive Regulatory Approval from New York State Department of Financial Services for Pending Acquisition

Western Union and International Money Express said New York State’s Department of Financial Services approved Western Union’s pending acquisition of Intermex. Western Union also made commitments to the regulator regarding remittance services and New York locations after the deal, according to the companies.

$WUMedAI 8/10

Western Union and Intermex Provide Update on Pending Acquisition

Western Union (NYSE: WU) and Intermex (NASDAQ: IMXI) said they received regulatory approval from New York’s DFS for Western Union’s pending acquisition of Intermex. They also reported a California DFPI letter suspending a previously granted approval extension, citing a need for further review. The companies plan to engage with DFPI to seek reinstatement and close after remaining conditions.

$WUMedAI 8/10

The Western Union Company: Western Union and Intermex Provide Update on Pending Acquisition

Western Union (NYSE: WU) and Intermex (NASDAQ: IMXI) updated on regulatory steps for Western Union’s pending acquisition of Intermex. NYDFS approved the deal and Western Union made commitments for New York remittance services and locations. Separately, California DFPI suspended an approval extension and the firms plan to seek reinstatement before closing.

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.